Department News

  • Leonard Named to Advisory Board of NIAAA Consortium
    9/11/23

    Kenneth E. Leonard, PhD, director of UB’s Clinical and Research Institute on Addictions, has been appointed to the Program Advisory Board of the National Consortium on Alcohol and Neurodevelopment in Adolescent-Adulthood (NCANDA-A).

  • Jacobs School Welcomes Undergraduates to Campus
    8/31/23

    The Jacobs School of Medicine and Biomedical Sciences welcomed incoming students to its building on the Buffalo Niagara Medical Campus in downtown Buffalo Aug. 25 as part of Undergraduate Academics Day.

  • Crane Hoists Massive MRI Into CTRC
    6/26/23

    UB is the first place in the nation to use the powerful Philips MR 7700 scanner solely for research that will prioritize underrepresented groups.

  • UB Awards 314 Biomedical Science Degrees; 18 Earn PhDs
    6/1/23

    Eighteen doctoral, 70 master’s and 226 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.

  • Zivadinov is Named SUNY Distinguished Professor
    5/26/23

    Robert Zivadinov, MD, PhD, professor of neurology and biomedical informatics in the Jacobs School of Medicine and Biomedical Sciences, has been named a SUNY Distinguished Professor, the highest rank in the SUNY system.

  • Blood Clot Claims About COVID-19 Vaccines Refuted
    4/14/23

    A study led by University at Buffalo researchers has confirmed that contrary to claims by anti-vaccine proponents, COVID-19 vaccines pose only trivial risk of venous thromboembolism (VTE), or blood clots. 

  • Samudrala, Falls Get Funding for Various Research Projects
    4/4/23

    Ram Samudrala, PhD, professor in the Department of Biomedical Informatics and chief of its Division of Bioinformatics, and Zackary M. Falls, PhD, assistant professor in the Department of Biomedical Informatics, have been involved in research that has resulted in four recent successful funding projects — three grants and a challenge.

  • Study Focuses on Brain Lesions, MS Progression
    2/24/23

    Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led by the University at Buffalo strongly suggests that the volume of white matter lesions is neither proportional to, nor indicative of, the degree of severe disability in patients. 

  • Jacobs School Researchers Capture ASPIRE Challenge
    2/21/23

    A group of researchers from the Jacobs School of Medicine and Biomedical Sciences were part of the team that captured the grand prize in a prestigious competition that was three years in the making.